| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-11 17:36:06 UTC |
|---|
| Update Date | 2021-09-26 23:13:00 UTC |
|---|
| HMDB ID | HMDB0256963 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | Pyridazine-3,6-diol |
|---|
| Description | Maleic hydrazide belongs to the class of organic compounds known as pyridazinones. Pyridazinones are compounds containing a pyridazine ring which bears a ketone. Based on a literature review a significant number of articles have been published on Maleic hydrazide. This compound has been identified in human blood as reported by (PMID: 31557052 ). Pyridazine-3,6-diol is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Pyridazine-3,6-diol is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | InChI=1S/C4H4N2O2/c7-3-1-2-4(8)6-5-3/h1-2H,(H,5,7)(H,6,8) |
|---|
| Synonyms | | Value | Source |
|---|
| Maleic acid hydrazide | MeSH | | Acid hydrazide, maleic | MeSH | | Hydrazide, maleic | MeSH | | Hydrazide, maleic acid | MeSH |
|
|---|
| Chemical Formula | C4H4N2O2 |
|---|
| Average Molecular Weight | 112.0868 |
|---|
| Monoisotopic Molecular Weight | 112.027277382 |
|---|
| IUPAC Name | 1,2,3,6-tetrahydropyridazine-3,6-dione |
|---|
| Traditional Name | stuntman |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | O=C1NNC(=O)C=C1 |
|---|
| InChI Identifier | InChI=1S/C4H4N2O2/c7-3-1-2-4(8)6-5-3/h1-2H,(H,5,7)(H,6,8) |
|---|
| InChI Key | BGRDGMRNKXEXQD-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as pyridazinones. Pyridazinones are compounds containing a pyridazine ring which bears a ketone. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Diazines |
|---|
| Sub Class | Pyridazines and derivatives |
|---|
| Direct Parent | Pyridazinones |
|---|
| Alternative Parents | |
|---|
| Substituents | - Pyridazinone
- Heteroaromatic compound
- Lactam
- Azacycle
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 1.99 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 8.0366 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.54 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 454.0 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 327.3 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 92.8 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 242.5 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 66.6 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 265.2 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 243.3 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 666.1 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 537.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 46.7 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 640.9 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 213.2 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 264.2 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 656.7 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 383.0 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 239.1 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Pyridazine-3,6-diol,1TMS,isomer #1 | C[Si](C)(C)N1[NH]C(=O)C=CC1=O | 1407.1 | Semi standard non polar | 33892256 | | Pyridazine-3,6-diol,1TMS,isomer #1 | C[Si](C)(C)N1[NH]C(=O)C=CC1=O | 1433.0 | Standard non polar | 33892256 | | Pyridazine-3,6-diol,1TMS,isomer #1 | C[Si](C)(C)N1[NH]C(=O)C=CC1=O | 1946.0 | Standard polar | 33892256 | | Pyridazine-3,6-diol,2TMS,isomer #1 | C[Si](C)(C)N1C(=O)C=CC(=O)N1[Si](C)(C)C | 1590.8 | Semi standard non polar | 33892256 | | Pyridazine-3,6-diol,2TMS,isomer #1 | C[Si](C)(C)N1C(=O)C=CC(=O)N1[Si](C)(C)C | 1660.7 | Standard non polar | 33892256 | | Pyridazine-3,6-diol,2TMS,isomer #1 | C[Si](C)(C)N1C(=O)C=CC(=O)N1[Si](C)(C)C | 1793.4 | Standard polar | 33892256 | | Pyridazine-3,6-diol,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1[NH]C(=O)C=CC1=O | 1642.0 | Semi standard non polar | 33892256 | | Pyridazine-3,6-diol,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1[NH]C(=O)C=CC1=O | 1692.4 | Standard non polar | 33892256 | | Pyridazine-3,6-diol,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1[NH]C(=O)C=CC1=O | 2014.5 | Standard polar | 33892256 | | Pyridazine-3,6-diol,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)C=CC(=O)N1[Si](C)(C)C(C)(C)C | 1951.8 | Semi standard non polar | 33892256 | | Pyridazine-3,6-diol,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)C=CC(=O)N1[Si](C)(C)C(C)(C)C | 2117.1 | Standard non polar | 33892256 | | Pyridazine-3,6-diol,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)C=CC(=O)N1[Si](C)(C)C(C)(C)C | 1918.7 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Pyridazine-3,6-diol GC-MS (Non-derivatized) - 70eV, Positive | splash10-03di-9500000000-f5330323db43f9bb6ad2 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Pyridazine-3,6-diol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | MS | Mass Spectrum (Electron Ionization) | splash10-03e9-9400000000-5660402a90273ab567b0 | 2014-10-20 | Not Available | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyridazine-3,6-diol 10V, Positive-QTOF | splash10-03di-0900000000-404b6cd62e19c5a04c10 | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyridazine-3,6-diol 20V, Positive-QTOF | splash10-03di-4900000000-38a7721dc374a821eb53 | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyridazine-3,6-diol 40V, Positive-QTOF | splash10-01tc-9100000000-81dcd3af33e231125c4a | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyridazine-3,6-diol 10V, Negative-QTOF | splash10-01ox-9400000000-34632b70bc6d26797f6f | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyridazine-3,6-diol 20V, Negative-QTOF | splash10-0006-9200000000-319866a718598df7f88d | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyridazine-3,6-diol 40V, Negative-QTOF | splash10-000x-9000000000-4b04b8bb9129d8150deb | 2016-08-03 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum |
|
|---|